Trial · NCT07887542
Effect of Home and Remote Blood Pressure Monitoring Via Home BP Monitoring System (HMS) on Adults With Hypertension in Taiwan
NCT07887542, Not applicable, Completed, National Taiwan University Hospital Hsin-Chu Branch
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effect of Home and Remote Blood Pressure Monitoring Via Home BP Monitoring System (HMS) on Adults With Hypertension in Taiwan. Trials, record NCT07887542. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07887542
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect of Home and Remote Blood Pressure Monitoring Via Home BP Monitoring System (HMS) on Adults With Hypertension in Taiwan
- NCT number
- NCT07887542
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 211 participants, actual
- Lead sponsor
- National Taiwan University Hospital Hsin-Chu Branch
- Conditions
- Hypertension
- Interventions
- Case-manager surveillance with physician-guided remote titration, Passive data review at clinic visits
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Office Systolic Blood Pressure | Baseline, month 6, month 12 | Office systolic blood pressure (mmHg) measured at the clinic visit, compared between the case-manager surveillance and passive data review conditions of the crossover design. |
| Primary | Office Diastolic Blood Pressure | Baseline, month 6, month 12 | Office diastolic blood pressure (mmHg) measured at the clinic visit, compared between the case-manager surveillance and passive data review conditions of the crossover design. |
| Primary | Home Systolic Blood Pressure | Baseline, month 6, month 12 | Mean home systolic blood pressure (mmHg), measured with the Omron HEM-7157T according to the 722 protocol: on 7 consecutive days at the start of each month, 2 sessions per day (morning and evening), 2 readings per session. Values are compared between the case-manager surveillance and passive data review conditions of the crossover design. |
| Primary | Home Diastolic Blood Pressure | Baseline, month 6, month 12 | Mean home diastolic blood pressure (mmHg) measured with the Omron HEM-7157T according to the 722 protocol (7 consecutive days at the start of each month, morning and evening, 2 readings per session), compared between the case-manager surveillance and passive data review conditions of the crossover design. |
| Primary | 24-Hour Mean Systolic Blood Pressure | Baseline, month 6, month 12 | Mean 24-hour systolic blood pressure (mmHg) on ambulatory blood pressure monitoring, compared between the case-manager surveillance and passive data review conditions of the crossover design. |
| Primary | 24-Hour Mean Diastolic Blood Pressure | Baseline, month 6, month 12 | Mean 24-hour diastolic blood pressure (mmHg) on ambulatory blood pressure monitoring, compared between the case-manager surveillance and passive data review conditions of the crossover design. |
| Secondary | Brachial-Ankle Pulse Wave Velocity | Baseline, month 6, month 12 | Brachial-ankle pulse wave velocity (m/s), measured with an automated oscillometric device, as a measure of arterial stiffness (target-organ damage). |
| Secondary | Number of Participants With Adverse Reactions Leading to Treatment Discontinuation | Up to month 12 | Participants with adverse reactions to antihypertensive treatment that led to discontinuation of a medication, recorded in the app or at clinic visits. |
| Secondary | Urine Albumin-to-Creatinine Ratio | Baseline, month 6, month 12 | Urine albumin-to-creatinine ratio (mg/g), as a measure of microalbuminuria (target-organ damage). |
| Secondary | ECG Voltage | Baseline, month 6, month 12 | Sokolow-Lyon voltage (SV1 + RV5 or RV6, mV) on 12-lead ECG, as a measure of left ventricular hypertrophy (target-organ damage). |
1 to 10 of 15Source ClinicalTrials.gov
See all 15 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07887542
GET https://conductscience.org/api/trials/v1/NCT07887542/registered